Oncolix Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Oncolix Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013308
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oncolix Inc (Oncolix) is a clinical stage biopharmaceutical company. It is developing a targeted therapeutic protein, Prolanta for the treatment of ovarian, breast and other cancers. Prolanta is a recombinant analogue to the human prolactin and acts as an antagonist to the prolactin receptor. Oncolix partners with other organizations such as BioVectra, Inc and Greenville Hospital System for the further development of Prolanta. It is also a member of BIO and BioHouston. The company works with various collaborators at The University Texas MD Anderson Cancer Center and developed the efficiency data in ovarian cancer. Oncolix is headquartered in Houston, Texas, the US.

Oncolix Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oncolix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Oncolix Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Oncolix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Oncolix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Oncolix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Oncolix Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Oncolix Raises USD0.3 Million in Venture Financing 10
Oncolix Raises USD0.2 Million in Financing 11
Oncolix Raises USD0.15 Million in Venture Financing 12
Oncolix Raises USD4.2 Million in Series A Financing 13
Oncolix Plans To Raise Additional US$5 Million In Venture Financing 14
Oncolix Raises US$2.4 Million In Venture Financing 15
Oncolix Raises US$1.5 Million In Venture Financing 16
Oncolix Raises US$0.05 Million In Venture Financing 17
Acquisition 18
Advanced Environmental Petroleum Producers Acquires Oncolix in Reverse Acquisition 18
Oncolix Inc – Key Competitors 19
Oncolix Inc – Key Employees 20
Oncolix Inc – Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Oncolix Inc, Pharmaceuticals & Healthcare, Key Facts 2
Oncolix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Oncolix Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Oncolix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Oncolix Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Oncolix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Oncolix Raises USD0.3 Million in Venture Financing 10
Oncolix Raises USD0.2 Million in Financing 11
Oncolix Raises USD0.15 Million in Venture Financing 12
Oncolix Raises USD4.2 Million in Series A Financing 13
Oncolix Plans To Raise Additional US$5 Million In Venture Financing 14
Oncolix Raises US$2.4 Million In Venture Financing 15
Oncolix Raises US$1.5 Million In Venture Financing 16
Oncolix Raises US$0.05 Million In Venture Financing 17
Advanced Environmental Petroleum Producers Acquires Oncolix in Reverse Acquisition 18
Oncolix Inc, Key Competitors 19
Oncolix Inc, Key Employees 20

★海外企業調査レポート[Oncolix Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AVBOB Mutual Assurance Society:企業の戦略・SWOT・財務分析
    AVBOB Mutual Assurance Society - Strategy, SWOT and Corporate Finance Report Summary AVBOB Mutual Assurance Society - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • DesignMedix Inc-製薬・医療分野:企業M&A・提携分析
    Summary DesignMedix Inc (DesignMedix) is a biotechnology company that develop drugs to overcome drug resistance in multiple diseases including malaria and diarrhea. The company focuses on the development of malaria cure drugs, malaria preventive drugs and anti-bacterial drugs. Its malaria cure drugs …
  • Protalix BioTherapeutics Inc (PLX):企業の財務・戦略的SWOT分析
    Protalix BioTherapeutics Inc (PLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Orkla ASA:企業の戦略・SWOT・財務情報
    Orkla ASA - Strategy, SWOT and Corporate Finance Report Summary Orkla ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Spitfire Oil Ltd (SRO):企業の財務・戦略的SWOT分析
    Summary Spitfire Oil Ltd (Spitfire) is an oil and gas company that produces and markets liquid hydrocarbons. The company's liquid hydrocarbons include fuel oil and distillate from the Salmon Gums Lignite Deposit. Its Salmon Gums Lignite deposit is located in Western Australia near Salmon Gums and co …
  • Alliancebernstein Holding Lp
    Alliancebernstein Holding Lp - Strategy, SWOT and Corporate Finance Report Summary Alliancebernstein Holding Lp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Oman Air (SAOC):企業の戦略・SWOT・財務情報
    Oman Air (SAOC) - Strategy, SWOT and Corporate Finance Report Summary Oman Air (SAOC) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Vexim SA – Product Pipeline Analysis, 2018 Uate
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • Candela Corp:企業の戦略的SWOT分析
    Candela Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Metalico, Inc.:企業の戦略的SWOT分析
    Metalico, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Capgemini SE:企業のM&A・事業提携・投資動向
    Capgemini SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Capgemini SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • FANUC CORPORATION:企業の戦略・SWOT・財務情報
    FANUC CORPORATION - Strategy, SWOT and Corporate Finance Report Summary FANUC CORPORATION - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Nightingale Informatix Corp (NGH)-医療機器分野:企業M&A・提携分析
    Summary Nightingale Informatix Corp (Nightingale) is a healthcare technology company that develops, markets and licenses application software and related services. The company offers practice management, billing solutions, medical records and interoperability products. It provides web based document …
  • BioLineRx Ltd (BLRX)-医療機器分野:企業M&A・提携分析
    Summary BioLineRx Ltd (BioLineRx) is a clinical stage biopharmaceutical company that focuses on the identification, in-licensing, and development of products to address unmet medical needs. The company’s product pipeline includes BL-8040, a short peptide for multiple cancer and hematological indicat …
  • Citizens Energy Group:企業の戦略的SWOT分析
    Citizens Energy Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Reckitt Benckiser Group Plc (RB.):企業の財務・戦略的SWOT分析
    Reckitt Benckiser Group Plc (RB.) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Icahn Enterprises LP:企業のM&A・事業提携・投資動向
    Icahn Enterprises LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Icahn Enterprises LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Ablynx NV (ABLX):製薬・医療:M&Aディール及び事業提携情報
    Summary Ablynx NV (Ablynx) is a biopharmaceutical company that focuses on developing Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. Nanobodies are a novel class of antibody-derived therapeutic proteins which possess structural and functional properties of nat …
  • Xerium Technologies Inc:企業の戦略的SWOT分析
    Xerium Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Co-Diagnostics Inc (CODX):企業の製品パイプライン分析
    Summary Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆